Meilin Liu

发表

A Unique Population of Regulatory T Cells in Heart Potentiates Cardiac Protection from Myocardial Infarction.

Yuzhi Lu, N. Xia, Xiang Cheng, 2020, Circulation.

Kinetics of tumor necrosis factor α in plasma and the cardioprotective effect of a monoclonal antibody to tumor necrosis factor α in acute myocardial infarction

J. Mehta, Xue-liang Du, Dayuan Li, 1999 .

Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. Correlation between antibody affinity and biological activity

S. Rafii, K. Hattori, P. Bohlen, 2003, Leukemia.

Involvement of the VEGF receptor 3 in tubular morphogenesis demonstrated with a human anti-human VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C

Zhen-ping Zhu, K. Persaud, J. Tille, 2004, Journal of Cell Science.

Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinoma.

Wenjie Zhu, Q. Zhan, H. Cui, 2022, Cancer cell.

Simultaneous Blockade of Both the Epidermal Growth Factor Receptor and the Insulin-like Growth Factor Receptor Signaling Pathways in Cancer Cells with a Fully Human Recombinant Bispecific Antibody*

P. Bohlen, Zhen-ping Zhu, Haifan Zhang, 2004, Journal of Biological Chemistry.

Targeting the platelet-derived growth factor receptor α with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: Implications as a potential therapeutic target

Peter Bohlen, Dan Lu, D. Hicklin, 2005, Molecular Cancer Therapeutics.

A recombinant, fully human, bispecific antibody neutralizes the biological activities mediated by both vascular endothelial growth factor receptors 2 and 3

Dan Lu, Zhen-ping Zhu, K. Persaud, 2005, Molecular Cancer Therapeutics.

Inhibition of fibroblast IL-6 production by ACKR4 deletion alleviates cardiac remodeling after myocardial infarction.

N. Xia, Xiang Cheng, Jiao Jiao, 2021, Biochemical and biophysical research communications.

Involvement of the VEGF receptor 3 in tubular morphogenesis demonstrated with a human anti-human VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C

Zhen-ping Zhu, J. Tille, X. Jimenez, 2004 .